top of page
Apr 7, 2021
Monitoring the proportion of the population infected by SARS-CoV-2
The Lancet Public Health Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Gianluca Severi, Touvier M, Zins M, de Lamballerie X,...
Mar 12, 2021
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana
Nat Commun Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H,...
Mar 1, 2021
Inhibition of the replication of SARSCoV-2 in human cells by the FDA-approved drug chlorpromazine
Int J Antimicrob Agents Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckiera F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachiai...
Jan 7, 2021
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study
Euro Surveill Bosetti P, Tran Kiem C, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S We used a mathematical model to evaluate...
Nov 2, 2020
Age-specific mortality and immunity patterns of SARS-CoV-2
Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating the size of...
Nov 2, 2020
Age-specific mortality and immunity patterns of SARS-CoV-2
Published in Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating...
bottom of page